These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 12564581)
1. NAS reports on potential risks of animal biotechnology. Kuehn BM; J Am Vet Med Assoc; 2003 Feb; 222(3):274-5. PubMed ID: 12564581 [No Abstract] [Full Text] [Related]
2. [Limits and risks of biotechnology in veterinary medicine from the viewpoint of the virologist]. Kaaden OR Dtsch Tierarztl Wochenschr; 1989 Feb; 96(2):47-8. PubMed ID: 2494030 [TBL] [Abstract][Full Text] [Related]
3. US animal biotech regulations "may not be adequate". Fox JL Nat Biotechnol; 2002 Oct; 20(10):959. PubMed ID: 12355099 [No Abstract] [Full Text] [Related]
4. Animal biotechnology. Environmental impact seen as biggest risk. Stokstad E Science; 2002 Aug; 297(5585):1257. PubMed ID: 12193761 [No Abstract] [Full Text] [Related]
6. FDA considering approval of genetically engineered salmon. Cima G J Am Vet Med Assoc; 2010 Nov; 237(9):1005-7. PubMed ID: 21090152 [No Abstract] [Full Text] [Related]
7. Gaps, inexperience, inconsistencies, and overlaps: crisis in the regulation of genetically modified plants and animals. Mandal GN William Mary Law Rev; 2004 Apr; 45(5):2167-259. PubMed ID: 16329219 [TBL] [Abstract][Full Text] [Related]
9. The ability of current biologics law to accommodate emerging technologies. Carter MJ Food Drug Law J; 1996; 51(3):375-80. PubMed ID: 11797714 [No Abstract] [Full Text] [Related]
11. A proposed design for conducting target animal safety studies for developing new veterinary pharmaceuticals. Carakostas MC; Colaianne JJ Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):49-54. PubMed ID: 8628920 [TBL] [Abstract][Full Text] [Related]
12. [New vaccines and new veterinary therapies derived from biotechnologies: examples of applications]. Vannier P; Martignat L Rev Sci Tech; 2005 Apr; 24(1):215-29. PubMed ID: 16110890 [TBL] [Abstract][Full Text] [Related]
13. New US committee considers xenotransplants. Fox JL Nat Biotechnol; 2001 Apr; 19(4):290-1. PubMed ID: 11283555 [No Abstract] [Full Text] [Related]
14. Current status of regulating biotechnology-derived animals in Canada: animal health and food safety considerations. Kochhar HP; Evans BR Theriogenology; 2007 Jan; 67(1):188-97. PubMed ID: 17097725 [TBL] [Abstract][Full Text] [Related]
15. A framework for the animal health risk analysis of biotechnology-derived animals: a Canadian perspective. Moreau PI; Jordan LT Rev Sci Tech; 2005 Apr; 24(1):51-60. PubMed ID: 16110876 [TBL] [Abstract][Full Text] [Related]
16. Genetically engineered animals in the food supply. Burns K J Am Vet Med Assoc; 2008 Nov; 233(9):1370-3. PubMed ID: 18980485 [No Abstract] [Full Text] [Related]
17. NAS set to study veterinary research trends. J Am Vet Med Assoc; 2003 Apr; 222(7):925. PubMed ID: 12685775 [No Abstract] [Full Text] [Related]
18. The end of big government? Miller HI Nat Biotechnol; 1997 Feb; 15(2):111. PubMed ID: 9035118 [No Abstract] [Full Text] [Related]
19. The regulation of veterinary regenerative medicine and the potential impact of such regulation on clinicians and firms commercializing these treatments. Nobert KM Vet Clin North Am Equine Pract; 2011 Aug; 27(2):383-91. PubMed ID: 21872766 [TBL] [Abstract][Full Text] [Related]
20. [Modern biotechnology: a new box for Pandora?]. Tramper J Tijdschr Diergeneeskd; 2002 Feb; 127(4):116-9. PubMed ID: 11885330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]